Combating Supply Chain Woes: Decentralize Your In-Clinic Diagnostic Testing

by | Nov 18, 2021 | Veterinary Diagnostics

Home » Veterinary Diagnostics » Combating Supply Chain Woes: Decentralize Your In-Clinic Diagnostic Testing

Disruptive innovation within pet care is happening. Veterinary hospitals and clinics are investing in top quality, molecular diagnostic testing capabilities at point-of-care, along upending traditional ways of doing business that finds them land-locked by unnecessary long-term contracts inhibiting their business models.

You all have experienced it at one time or another over the past 18 months. Two-day shipping on Amazon? Gone. Rental cars?  You’ll have better luck finding a Dunkin’ Donuts in Seattle.  Christmas shopping?  Start now, don’t wait for Black Friday.

Veterinary diagnostic testing is not exempt. What used to take a couple days to receive results from reference labs now is taking more than a week.  And if a per test price isn’t locked in, well, let’s just say we may not want to go there.

The landscape has changed and continues to change.  Just in the past 30 years, businesses like Fotomat and Blockbuster have given way to cloud-based viewing of pictures and streaming service from the comfort of your personal space. Businesses have watched the transition from mainframes to desktops to laptops which have enabled hybrid work environments. Self-check outs and ride share apps are now the norm.

What does this all mean?  Society and businesses are becoming less dependent on centralized services.  Individual and business customers want speed, reduced cost, and better control.  Most vet practices are held to the status quo of waiting three, five, and sometimes 10 days for an answer from a reference lab while pet owners are expecting near instant results. These paradigms are not only at opposite ends of the spectrum, but they come with inherent risks. Rising costs, shipping delays, and labor shortages to transport and process the tests contribute to delays in proper treatments.

More than ever, vet practices are looking for efficient and cost-effective methodologies to take control of these variables and manage costs while providing best-in-class treatment for the patient. In-sourcing diagnostic testing is one solution. LexaGene’s MiQLab provide in-clinic diagnostic testing of up to 27 pathogens and antimicrobial resistance markers for 4 classes of resistance in ~2 hours.

Interested in talking to someone about our solution? Email us.

Download our MiQLab™ System for Veterinary Diagnostics brochure to learn more.

<a href="" target="_self">Joe Fillion</a>

Joe Fillion

Joe Fillion is a business development and strategic marketing professional specializing in identifying and developing winning strategies that bring disruptive technologies, products, and worldwide markets together. As LexaGene’s Market Development Manager, Joe is responsible for developing “go to market” strategies, product launch plans, creating and executing business development strategies, and identifying, researching, and developing new markets. Joe has a Bachelor of Science degree from DeVry Institute of Technology in Electronic Engineering and an MBA from Southern New Hampshire University with a concentration in international marketing.

There is Even a Black Friday for Buying Capital Equipment

LexaGene’s MiQLab has direct benefits for veterinary clinics. Using LexaGene’s proven point-of-care diagnostics for evidence-based treatment of common bacterial infections found in companion animals may also result in cost savings.

Red Rover, Red Rover, Send PCR Testing Over

When thinking about how best to isolate a bacterium, scientists were often held to the standards of taking time to grow cultures in laboratories, a process involving days or weeks to simply prepare the sample for testing. In today’s everchanging world, LexaGene’s MiQLab™ now allows for samples to be captured at point-of-care, inserted into a cartridge, mixed with a reagent, and run through a testing system, shortening the time to result to hours instead of days.

What the Heck is a Mycoplasma and Why Doesn’t Anyone Like Them?

The global bioburden testing market for bio-pharma contamination is approximately $10B, with over 350M tests run annually. LexaGene provides early detection for mycoplasma, aiding in validating product quality for biopharmaceutical manufacturers.

Upcoming Events

Southwest Veterinary Symposium

San Antonio
September 23, 2021 - September 26, 2021
Southwest Veterinary Symposium represents innovative partnerships that focus on creating an unparalleled education experience, advancing the entire veterinary profession, and fostering a spirit of reciprocal investment among our partner VMAs, attendees, and exhibitors.

Latest Resources

See how easy to use the MiQLabTM system is to detect pathogens and other molecular markers for a wide range of point-of-need applications.